Adverse drug events caused by medication errors in medical inpatients

Swiss Medical Weekly

Volumn 134, Issue 45-46, 2004, Pages 664-670

  Hardmeier, Beat ^a   Braunschweig, Suzanne ^a,b   Cavallaro, Marzia ^a   Roos, Malgorzata ^c   Pauli Magnus, Christiane ^a   Giger, Max ^a   Meier, Peter J ^a   Fattinger, Karin ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Adverse drug events; Adverse drug reactions; Medical inpatients; Medication error; Preventable adverse drug events

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; CARDIOVASCULAR AGENT; CEFTRIAXONE; CLOZAPINE; COTRIMOXAZOLE; DECONGESTIVE AGENT; DICLOFENAC; DIGOXIN; FLURBIPROFEN; HEPARIN; ILOPROST; INSULIN; IRON; LORAZEPAM; METOPROLOL; MIDAZOLAM; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENPROCOUMON; SEDATIVE AGENT;

ABDOMINAL CRAMP; ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; BRADYCARDIA; DISEASE EXACERBATION; DRUG CONTRAINDICATION; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG SURVEILLANCE PROGRAM; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATOMA; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; HYPOTENSION; KIDNEY FAILURE; LIVER FAILURE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; MUSCLE HEMATOMA; NAUSEA; PHLEBITIS; PREVENTIVE MEDICINE; RASH; RESPIRATORY FAILURE; RHINITIS; SKIN EDEMA; SLEEP APNEA SYNDROME; SOMNOLENCE; SUBDURAL HEMATOMA; THROMBOCYTOPENIA; VISUAL IMPAIRMENT; VOMITING;

EID: 10944239448     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med 2004;140:795-801.
2. Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Fortnightly review: Adverse drug reactions. BMJ 1998;316: 1295-8.
3. Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998;45:301-8.
4. Fattinger K, Roos M, Vergeres P, Holenstein C, Kind B, Masche U, et al. Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine. Br J Clin Pharmacol 2000;49:158-67.
5. Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991;324:377-84.
6. Thomas EJ, Brennan TA. Incidence and types of preventable adverse events in elderly patients: population based review of medical records. BMJ 2000;320:741-4.
7. Kaushal R, Bates DW, Landrigan C, McKenna KJ, Clapp MD, Federico F, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001;285:2114-20.
8. Bates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape L. Relationship between medication errors and adverse drug events. J Gen Intern Med 1995;10:199-205.
9. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995;274:29-34.
10. Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med 1993;8:289-94.
11. Kohn LT, Corrigan JM, Donaldson MS. To Err is Human: Building a Safer Health System Washington DC, USA: National Academy Press; 1999.
12. Anderson RE. How many deaths are due to medical errors? JAMA 2000;284:2188.
13. Hughes CM. How many deaths are due to medical errors? JAMA 2000;284:2187.
14. Honig P, Phillips J, Woodcock J. How many deaths are due to medical errors? JAMA 2000;284:2187-8.
15. Feinstein AR, Cicchetti DV High agreement but low kappa: I. The problems of two paradoxes. J Clin Epidemiol 1990;43:543-9.
16. Cicchetti DV, Feinstein AR. High agreement but low kappa: II. Resolving the paradoxes. J Clin Epidemiol 1990;43:551-8.
17. Wissenschaftliche Tabellen Geigy, Teilband Statistik. 8. Edition, Basel; 1980.
18. Wilson RM, Runciman WB, Gibberd RW, Harrison BT, Newby L, Hamilton JD. The Quality in Australian Health Care Study. Med J Aust 1995;163:458-71.
19. Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 1995;274:35-43.
20. Bates DW, Miller EB, Cullen DJ, Burdick L, Williams L, Laird N, et al. Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. Arch Intern Med 1999;159:2553-60.
21. Thomas EJ, Lipsitz SR, Studdert DM, Brennan TA. The reliability of medical record review for estimating adverse event rates. Ann Intern Med 2002;136:812-6.
22. Hayward RA, Hofer TP. Estimating hospital deaths due to medical errors: preventability is in the eye of the reviewer. JAMA 2001;286:415-20.
23. Chertow GM, Lee J, Kuperman GJ, Burdick E, Horsky J, Seger DL, et al. Guided medication dosing for inpatients with renal insufficiency. JAMA 2001;286:2839-44.
24. Juntti Patinen L, Neuvonen PJ. Drug-related deaths in a university central hospital. Eur J Clin Pharmacol 2002;58:479-82.
25. Ebbesen J, Buajordet I, Erikssen J, Brors O, Hilberg T, Svaar H, et al. Drug-related deaths in a department of internal medicine. Arch Intern Med 2001;161:2317-23.